what biotechs need to know about fundraising in the midst of covid-19
Published 4 years ago • 314 plays • Length 1:00:10Download video MP4
Download video MP3
Similar videos
-
1:02:19
cell and gene therapy market access in a covid-19 world: challenges and opportunities
-
1:01:40
cell therapy treatments for covid-19
-
1:00:24
panel: the lasting covid-19 impact on cell and gene therapy
-
3:58
the benefits of preventative care & regenerative medicine
-
54:13
safely maintaining effective biotech operations and research during covid-19
-
12:23
the future of regenerative therapies | kenro kusumi | tedxasuwest
-
11:39
can stem cells shape the future of medicine? | esther wolfs | tedxuhasselt
-
6:52
how cambridge became a biotech hub
-
1:00:48
how has covid-19 affected biopharma?
-
59:47
biotech showcase 2018: what it means to be in the era of cures
-
8:48
covid-19 therapeutics will be available before a vaccine, says 10x genomics ceo
-
1:00:23
panel: alternate ipo strategies fo cell and gene therapy companies
-
20:09
creating curative therapies | brock reeve | tedxboston
-
0:42
what does 'longevity' really mean to you?
-
37:27
coronavirus and the future of immunotherapy with prof. dr. isaiah arkin
-
6:46
biotech is ‘the superhero of the pandemic’: investor
-
47:40
biotech and healthcare through 2020 and beyond
-
6:11
the next breakthroughs in biotech
-
4:07
why there is opportunity in biotech and the names to watch
-
3:24
barbara ryan: what's working in health care and biotech | cnbc
-
31:30
from sick care to preventative care: rethinking medicine